On on Tuesday the US Supreme Court declined to review the dismissal of a lawsuit involving a group of California pharmacists who allege Pfizer conspired with Ranbaxy Laboratories to delay sales of generic versions of its cholesterol drug Lipitor.
The justices let stand a ruling by the 3rd US Circuit Court of Appeals in Philadelphia dismissing the pharmacists’ case on the grounds that the lawsuit failed to allege a violation of California antitrust law.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
... THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 216.73.216.190
Please verify email or join us
to access premium content!
